Allyl isothiocyanate as a potential inducer of paraoxonase-1 - Studies in cultured hepatocytes and in mice

IUBMB Life

Volumn 64, Issue 2, 2012, Pages 162-168

  Schrader, Charlotte ^a   Graeser, Anne Christin ^a   Huebbe, Patricia ^a   Wagner, Anika E ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

atherosclerosis; hepatocytes; isothiocyanates; mice; paraoxonase 1

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; ALLYL ISOTHIOCYANATE; ARYLDIALKYLPHOSPHATASE 1; BUTYL ISOTHIOCYANATE; ISOTHIOCYANIC ACID DERIVATIVE; MESSENGER RNA; PHENETHYL ISOTHIOCYANATE; SULFORAPHANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME INDUCTION; FEMALE; HEPATOCYTES; HUMANS; ISOTHIOCYANATES; LIVER; MICE; MICE, INBRED C57BL; THIOCYANATES; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 84855901818     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.587     Document Type: Article

References (31)

1. Parthasarathy, S., Santanam, N., Ramachandran, S., and, Meilhac, O., (1999) Oxidants and antioxidants in atherogenesis. An appraisal. J. Lipid Res. 40, 2143-2157.
2. Virgili, F., Ambra, R., Muratori, F., Natella, F., Majewicz, J., et al. (2003) Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells. Antioxid. Redox. Signal 5, 237-247. (Pubitemid 36457599)
3. Gerrity, R.G., (1981) The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103, 181-190. (Pubitemid 11112973)
4. Berliner, J. A., and, Heinecke, J.W., (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707-727. (Pubitemid 26105783)
5. Nicholson, A. C., Han, J., Febbraio, M., Silversterin, R. L, and, Hajjar, D. P., (2001) Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann. N. Y. Acad. Sci. 947, 224-228. (Pubitemid 34059917)
6. Steinbrecher, U. P., (1999) Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta. 1436, 279-298. (Pubitemid 29242910)
7. Zingg, J. M., Ricciarelli, R., and, Azzi, A., (2000) Scavenger receptors and modified lipoproteins: fatal attractions? IUBMB Life 49, 397-403. (Pubitemid 30436174)
8. Mackness, M., and, Mackness, B., (2004) Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic. Biol. Med. 37, 1317-1323.
9. Fuhrman, B., Gantman, A., and, Aviram, M., (2010) Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis. Atherosclerosis 211, 61-68.
10. Shih, D.M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., et al. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394, 284-287. (Pubitemid 28335041)
11. Tward, A., Xia, Y. R., Wang, X. P., Shi, Y. S., Park, C., et al. (2002) Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106, 484-490. (Pubitemid 34803695)
12. Rosenblat, M., Volkova, N., Ward, J., and, Aviram, M., Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation. Atherosclerosis, 2011, in press.
13. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S., Harvey, I., et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88, 38-50. (Pubitemid 351988681)
14. Bones, A., and, Rossiter, J. T., (1996) The myrosinase-glucosinolate system, its organisation and biochemistry. Physiol. Plant. 97, 194-208. (Pubitemid 126616896)
15. Ernst, I. M., Wagner, A. E., Schuemann, C., Storm, N., Hoppner, W., et al. (2010) Allyl-, butyl- and phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts. Pharmacol. Res. 63, 233-240.
16. Wagner, A. E., Ernst, I., Iori, R., Desel, C., and, Rimbach, G., (2010) Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp. Dermatol. 19, 137-144.
17. Gouedard, C., Barouki, R., and, Morel, Y., (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 24, 5209-5222. (Pubitemid 38738157)
18. Borenfreund, E., and, Puerner, J. A., (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24, 119-124. (Pubitemid 15103513)
19. Valacchi, G., Rimbach, G., Saliou, C., Weber, S. U., and, Packer, L., (2001) Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology. 165, 225-234. (Pubitemid 32778315)
20. Gaedicke, S., Zhang, X., Schmelzer, C., Lou, Y., Doering, F., et al. (2008) Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 582, 3542-3546.
21. Thomson, S. J., Brown, K. K., Pullar, J. M., and, Hampton, M. B., (2006) Phenethyl isothiocyanate triggers apoptosis in Jurkat cells made resistant by the overexpression of Bcl-2. Cancer Res. 66, 6772-6777. (Pubitemid 44085636)
22. Ye, L., Dinkova-Kostova, A. T., Wade, K. L., Zhang, Y., Shapiro, T. A., et al. (2002) Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta. 316, 43-53. (Pubitemid 34028187)
23. Hanlon, N., Coldham, N., Gielbert, A., Kuhnert, N., Sauer, M. J., et al. (2008) Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br. J. Nutr. 99, 559-564. (Pubitemid 351223423)
24. Liebes, L., Conaway, C. C., Hochster, H., Mendoza, S., Hecht, S. S., et al. (2001) High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal. Biochem. 291, 279-289. (Pubitemid 32373163)
25. Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Amos, C. I., et al. (2000) Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 9, 1017-1020.
26. Mackness, B., Beltran-Debon, R., Aragones, G., Joven, J., Camps, J., et al. (2010) Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 62, 480-482.
27. Khateeb, J., Gantman, A., Kreitenberg, A. J., Aviram, M., and, Fuhrman, B., (2010) Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis 208, 119-125.
28. Boesch-Saadatmandi, C., Niering, J., Minihane, A. M., Wiswedel, I., Gardeman, A., et al. (2010) Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis 211, 110-113.
29. Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., et al. (2004) An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism 53, 153-158. (Pubitemid 38168885)
30. Zhang, Y., Li, J., and, Tang, L., (2005) Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. Free Radic. Biol. Med. 38, 70-77. (Pubitemid 39626910)
31. Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., et al. (1998) Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol 18, 1617-1624. (Pubitemid 28465415)